Supplier sign in
Home
STAY INFORMED
Subscribe to our monthly newsletter.
Your email address will never be disclosed to any third party.
Read our privacy notice.

     

News items January 2021

Post your news
Organocatalysts Available at Alfa Chemistry Catalysts: High Quality and Cost-Effective
Organocatalysts Available at Alfa Chemistry Catalysts:
High Quality and Cost-Effective Catalysts, when a substoichiometric quantity of an organic compound is added, can accelerate chemical reactions. The last few years has seen a spectacularly increasing interest in organocatalysts. To better serve its customers across the globe, Alfa Chemistry Catalysts recently announced to provide a comprehensive range of organocatalysts, which are cost-effective and of high quality, for both research and industrial use. Organocatalysis uses small organic molecules predominantly composed of C, H, O, N, S and P to accelerate chemical reactions. The reason for the popularity of organocatalysts is that the efficiency and selectivity of many organocatalytic reactions can meet the standards of established organic reactions. Hence, organocatalytic reactions are becoming powerful tools in the construction of complex molecular skeletons. “The advantages of organocatalysts include their ready availability, low cost, and low toxicity, which confers a huge direct benefit in
20-01-2021  |  002x  |  Industry news  | 
Alfa Chemistry Materials Upgrades Magnetic Materials for Researchers and Manufacturers
Alfa Chemistry Materials Upgrades Magnetic Materials
for Researchers and Manufacturers Magnetic materials are of technological importance because they are key components of motors, generators, and transformers. On December 22, 2020, Alfa Chemistry Materials, known as a provider of wide ranges of materials and chemicals, announced to have upgraded its supply of magnetic materials. Now, magnetic ionic liquids, magnetic metal complexes, and organic radicals can be easily accessed at this company. Magnetic materials are extensively studied and used mainly for their magnetic properties. Their magnetic responses are largely determined by the magnetic dipole moment associated with the intrinsic angular momentum, or spin, of its electrons. “In recent years, magnetic materials have been found to play a a major role in numerous fields, for example, power generation and transmission, electronic appliances, analogue and digital data storage as well as medical appliances like magnetic resonance imaging (MRI), magnetic therapy and drug delivery, sensors and actuators,
20-01-2021  |  000x  |  Product news  | 
Creative Diagnostics Announces SARS-CoV-2 Antibody Pairs
Creative Diagnostics Announces SARS-CoV-2 Antibody Pairs
As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces further expansion of its SARS-CoV-2 related product portfolio with the launch of the SARS-CoV-2 antibody pairs against the nucleoprotein antigens of SARS-CoV-2. These antibodies were screened from thousands of clones and selected for their high sensitivity and specificity in lateral flow applications. Creative Diagnostics now provides a variety of antigens and antibodies of SARS-CoV-2, including SARS-CoV-2 mutant proteins, biotinylated proteins, SARS-CoV-2 antibody pairs, neutralizing antibodies and so on. These antigens and antibodies can be used for scientific research, detection of SARS-CoV-2 and specific antibodies. All of Creative Diagnostics products are produced using a standardized production process to ensure the highest quality. These newly released SARS-CoV-2 antibodies are validated for rapid antigen assays and can be used
19-01-2021  |  013x  |  Product news  | 
Want a Quick Q&A for Exosomes? Read This
Want a Quick Q&A for Exosomes? Read This
In recent years, biomimetic nanomedicine combined with the unique functions of natural biomaterials and the versatility of artificial nanomaterials has attracted widespread attention for drug delivery. In 2019, the study Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy published in Nature Communications have showed that exosomes-biomimetic nanoparticles have the potential to improve anti-cancer efficacy as drug carriers. Moreover, because such nanoparticles can effectively kill tumor stem cells, it is expected to solve major problems such as tumor recurrence, metastasis and drug resistance. Exosomes are cell vesicles that contain complex RNA and proteins. Their size is in the nanometer range (30-150 nanometers in diameter), and they can be secreted by a variety of cells under normal and pathological conditions. Exosomes are mainly derived from multivesicular bodies formed by intracellular lysosomal microparticles, which are released into
19-01-2021  |  014x  |  Product description  | 
Diagnostic Enzymes Portfolio for Medical and Research Diagnosis Creative Enzymes Launched Complete Diagnostic Enzymes Portfolio for Medical and Research Diagnosis
Diagnostic Enzymes Portfolio for Medical and Research Diagnosis
Creative Enzymes Launched Complete Diagnostic Enzymes Portfolio for Medical and Research Diagnosis Creative Enzymes, the world`s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and enzyme-related customized services for medical and research diagnosis. Relying on its professional team and the most advanced technology, as well as high-quality products and services, it has gained solid reputation. Recently, the product manager of Creative Enzymes announced that the company has launched a complete product portfolio of enzymes for medical and research diagnosis Creative Enzymes`s diagnostic enzyme product line covers a wide range of application areas, including but not limited to blood lipids, clinical diagnosis, diabetes, kidney & pancreas function, liver function, POCT biosensor. Each product has a detailed description, source, form, activity and other biochemical properties. “Our team is comprised of experts in enzymology, microbiology, immunology and pharmacology with years of experience in academia
15-01-2021  |  043x  |  Industry news  | 
Vaisala to expand its Indigo product range with HMP1 probe New HMP1 probe for humidity and temperature measurements in high-end facilities
Vaisala to expand its Indigo product range with HMP1 probe
New HMP1 probe for humidity and temperature measurements in high-end facilities The new HMP1 probe provides the best performance for measurements in critical production and storage facilities as well as in locations such as data centers where measurement accuracy, easy maintenance, and robustness are crucial. Vaisala, a global leader in weather, environmental, and industrial measurements, has today introduced a new HUMICAP® Humidity and Temperature Probe HMP1. With its top-of-the-line accuracy and sensor purge functionality that ensures excellent stability over time, the HMP1 is an ideal choice for demanding humidity measurements in environments such as pharmaceutical facilities, data centers, cleanrooms, or any other environments that require strict humidity monitoring and control. The product features the recognized and space-proof HUMICAP® sensor technology, which is known to endure demanding conditions. The HMP1 complements the Indigo product family, which is a premium solution for multi-parameter measurements with flexible connectivity.
15-01-2021  |  036x  |  Product news  | 
Creative BioMart Microbe Provides One-stop Microbial Protein Expressio
As a company backed by years of experience in the microbiology service industry, Creative BioMart Microbe now provides customers with high-standard microbial protein expression system related services to help customers solve problems in research and shorten the research cycle. The expression of recombinant proteins using microorganisms is the basic work used for protein production and property research, and the common microbial expression systems mainly include E. coli expression system, yeast expression system and filamentous fungal expression system. Microbial expression system is an important expression source for commercial proteins due to its advantages of simple culture, short periodicity, and low cost. Creative BioMart Microbe has rich experience in microbial protein expression services and can provide customers with one-stop services from gene synthesis, vector construction, gene expression to protein purification. Its services cover a variety of microbial
15-01-2021  |  028x  |  Product news
Bioinfo Platform Helps Discover Hidden Potential in Biological Data CD Genomics`s Bioinformatics-analysis Division Help Discover Hidden Potential in Biological Data
Bioinfo Platform Helps Discover Hidden Potential in Biological Data
CD Genomics`s Bioinformatics-analysis Division Help Discover Hidden Potential in Biological Data Established in 2004, CD Genomics is a genomics service company with a good reputation. Recently, the vice president of CD Genomics announced the newly developed division - Bioinformatics-analysis division, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business, based on functional genomics BT+IT (high-throughput gene sequencing technology, biological information technology, high-performance biological cloud computing technology) technology, CD Genomics provides sequencing platform and bioinformatics analysis platform. These platforms are equipped with advanced equipment and experienced scientists to assist all types of sequencing fields. The bioinformatics analysis team provides various bioinformatics analysis services related to genomics, transcriptomics, microbiology, epigenetics, proteomics and metabolomics, and other
14-01-2021  |  059x  |  Industry news  | 
Give your old/used AAS a 2nd life Are there any surplus AAS Systems dusting in your warehouse or in the corner of your laboratory?
Give your old/used AAS a 2nd life
Are there any surplus AAS Systems dusting in your warehouse or in the corner of your laboratory? Currently Labrecycling is searching for AAS systems and is asking for your help. We get more and more demands for Atomic Absorption Spectrometers. We search among other things: •Varian 220 S, 240FS, 280FS •Shimadzu AA700 •Agilent 200 Series Labrecycling recycles chromatographic instruments and has room to take over your equipment. Throwing away is a sin. What do you do with old chromatography equipment? Many laboratories in the Netherlands and Belgium have old equipment, which is dusting in a corner of the laboratory or warehouse. And then…? We offer you the solution, whereby in most cases it is not only collected by us, but also gets a second life. What we ask of you is a photo with a short description to WhatsApp or email us. It will only take you a few minutes. You will hear within a day, whether we can take over from you. The information we only need from you is: 1. Manufacturer and model 2. Detailed photo or photos 3. Year of purchase 4. Are PC and software
14-01-2021  |  020x  |  Product news  | 
ISFET pH probe for general laboratory use
CupFET: Robust pH probe for droplet volumes Wellinq Sensor Solutions offers a comprehensive line of high quality meters and probes for glass-free pH measurement. The SI meter and probe line is created around our proprietary ISFET pH sensor that offers accurate and reliable pH measurement for demanding applications. Web shop The pH probes, meters and additional accessories are available in the web shop at the Wellinq Sensor Solutions website. Robust pH probe for droplet volume samples The CupFET pH probe is especially designed for measurement of small volume samples. Measurements can be performed by placing as little as a single droplet of liquid directly onto the probe’s cup shaped tip. Wellinq’s customers use the CupFET probes to directly measure the pH of fruit in the field by pressing a droplet of juice onto the probe tip. Similarly, in laboratories or industrial processes, they pipet droplets directly onto the CupFET probe tip to measure the pH of samples. Applications for which Wellinq’s customers use pH
14-01-2021  |  026x  |  Product news
GutFlora Omics Platform Offers Gut Microbiota Bioinformatics Services Gut Microbiota Bioinformatics Services Now Available by the GutFlora Omics Platform of Creative Proteomics
GutFlora Omics Platform Offers Gut Microbiota Bioinformatics Services
Gut Microbiota Bioinformatics Services Now Available by the GutFlora Omics Platform of Creative Proteomics GutFlora Omics platform belongs to Creative Proteomics. It has more than 10 years of experience in providing advanced multi-omics services, and provides services and support to customers through comprehensive intestinal flora research solutions. The product manager has recently announced the fully-developed gut microbiota bioinformatics services, which help understand how the gut microbiota colonizes, varies and interacts with the host, and even how to associate with diseases can be of great value in the treatment of these diseases, such as inflammatory bowel disease (IBD), diabetes, mental disorders, and cancers. Intestinal flora, as the general term for the microbial community that resides in the human intestine, is one of the most interesting research focuses in the fields of microbiology, medicine, and genetics in recent years. Research in recent years has gradually revealed the composition and quantity of intestinal flora, how it enters the body, how to assist
14-01-2021  |  035x  |  Industry news  | 
The SYMAX double syringe pump. A technical innovation. Ideal for applications where the smallest volumes of liquid have to be dosed very precisely
The SYMAX double syringe pump. A technical innovation.
Ideal for applications where the smallest volumes of liquid have to be dosed very precisely For the pulsation-free delivery of small volumes of liquids, syringe pumps have been very successful in atomic spectroscopy, the chemical industry or research, as well as in medical technology. In a previous publication, Spetec was able to show that syringe pumps are excellently suited in atomic spectroscopy for the analysis of cell suspensions or nanoparticle suspensions in order to reduce memory effects or blank values. In medical technology, syringe pumps are indispensable for dosing liquid infusions. For long-term applications, there used to be the handicap that the syringes had to be replaced manually for applications that were to run with the same liquid over a long period of time. Thanks to a technical innovation, Spetec GmbH has now succeeded in developing a double syringe pump that no longer has this disadvantage. A simple spindle with offset power transmission to the syringe pushers, driven by a stepper motor, makes it possible to drive two separate syringes
14-01-2021  |  022x  |  Product news  | 
Curve Therapeutics to Digitalize its Drug Discovery Platform with CDD Innovative end-to-end scientific research to be managed in CDD Vault
Curve Therapeutics to Digitalize its Drug Discovery Platform with CDD
Innovative end-to-end scientific research to be managed in CDD Vault Burlingame, California — December 16, 2020 —Collaborative Drug Discovery (CDD) has today announced that its CDD Vault platform will be implemented by Curve Therapeutics Ltd. (Southampton, UK) to manage its genetically-encoded Microcycle platform and the functional hits and leads generated from it. Curve is an innovative drug discovery company that has developed a screening platform that directly identifies functional modulators of disease targets in their native cellular environment. CDD Vault is a ubiquitous, hosted platform used by research teams at pharma, academia, and biotechs to store, mine and manage chemical, biological, and image data from the discovery process. It allows the secure and seamless sharing of data with external partners in real-time thus facilitating true collaborative discoveries. "It is important that all of our data is easily captured, mined and analyzed and CDD Vault has been straightforward to implement and use. The system will allow us
14-01-2021  |  026x  |  Industry news  | 
Jubilant Biosys` Digital Data Transformation: A Case Study
Jubilant Biosys` Digital Data Transformation: A Case Study
Jubilant Biosys, a major international contract research organization (CRO), provides comprehensive drug discovery services to the global pharmaceutical industry. The company adopted CDD Vault and digitally transformed its data management, resulting in increased research productivity and customer satisfaction. “Jubilant Biosys’ customers are now able to see their project evolution as it happens, which is a clear advantage for a biotech or pharma when choosing a partner to work in a discovery project” said Remy Hoffmann, Sr Director BD Europe. “The platform facilitates the close interaction between researchers at Jubilant and their project originator counterpart. This real-time conversation makes for true collaborative projects." Read the full case study on Drug Discovery World.
14-01-2021  |  027x  |  Industry news  | 
UK government can deliver Brexit benefit with medicines security
Company forewarns the UK is risking fake COVID-19 vaccines and other medicines without a new system The UK is now facing a significant problem in how it secures the country’s medicines’ supply chain after leaving the EU on January 1st. But rather than view this as an insurmountable problem, FarmaTrust – a UK-based global medical authentication provider – is calling on the UK government to be true to its word and deliver new Brexit benefits. This issue is especially important with the world’s largest ever mass immunisation program currently under way for COVID-19 vaccines – with both AZ and Pfizer vaccines now being rolled out – at the same time as our only means of verifying authenticity is revoked. This issue of drug supply security and authenticity has only been mentioned in passing in Brexit coverage to date, yet many experts warn that the UK’s departure from the EU’s Falsified Medicines Directive (FMD) has created a huge potential risk. FarmaTrust is calling on the Government to seize the initiative and take this as an opportunity to modernise the system and
13-01-2021  |  022x  |  Industry news
CD Bioparticles Releases New Block Copolymer Micelles for Drug Deliver
CD Bioparticles Releases New Block Copolymer Micelles for Drug Deliver
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles launches a series of block copolymer micelles for global researchers to help solve the challenges faced in the studies such as limited drug-loading efficiency and yield, unpredictable or uncontrollable degradation rate of the drug-loading cargo, or uncontrollable drug delivery profile. These newly released products are applicable for a variety of potential usages, like biocompatible and biodegradable nanomaterials and bulk material fabrications, drug-delivery cargos with controllable delivery profile, and hydrogels with sol-gel transition useful for reversible encapsulation and delivery. Many new products are released in the block copolymer micelles portfolio, such as Triblock Copolymers, which are vinylically reactive for binding into radical chain synthesized polymers, and AB Diblock Copolymers. For the latter products, the Acrylate-polycaprolactone-b-poly(ethylene
12-01-2021  |  031x  |  Product news  | 
BOC Sciences comprehensively deploys liposomal drug delivery research
BOC Sciences comprehensively deploys liposomal drug delivery research
Recently, Anna, the chief scientist of BOC Sciences’s liposome technology platform, and her colleagues successfully developed a breakthrough technology that can solve the key problems in liposomal drug delivery. This technology can effectively prolong the blood circulation time of different modified types of liposomes, improve the treatment efficiency of encapsulated drugs, and reduce adverse reactions caused by drug leakage. "This technology has been successfully validated in mouse models. Compared with mice receiving conventional liposome treatment, mice modified with liposomes with this new technology can significantly reduce tumor cells. This simple and effective method is easy to be widely used, and it should be improved as soon as possible for clinical use. "Anna said. Advantages of liposomal drug delivery Liposomes are considered to be highly common and well-studied nanocarriers for targeted drug delivery. And liposomes can be defined as phospholipid vesicles,
08-01-2021  |  045x  |  Industry news  | 
BOC Sciences’s CDMO Helps Overcome the Last Hurdle of ADC R&D
BOC Sciences’s CDMO Helps Overcome the Last Hurdle of ADC R&D
The past decade has been a decade of accumulation and harvest of antibody-conjugated drugs (ADC). Breakthroughs have been made in the bottleneck of ADC research, the door to success has been opened, and more and more antibody-conjugated drugs have entered the research and development pipeline. However, the research team of ADC drugs is still facing huge R&D and production challenges. Recently, BOC Sciences announced that it will provide one-stop CDMO services to help overcome the challenges in the R&D and production of ADC drugs. In the past, ADC R&D researchers needed to collaborate with at least 4 CDMOs on mAb, payload, linker, and conjugation methods respectively to promote ADC to clinical trials and the market. Moreover, if the partners are located in different countries and regions, ADC R&D researchers will face the challenges of a complex global supply chain. With the continuous advancement of ADC drug clinical research and the rising demand for commercialization,
08-01-2021  |  057x  |  Product news  | 
WuXi STA’s Integrated CMC Platform Supports InnoCare Orelabrutinib App
STA Pharmaceutical, a WuXi AppTec Company (WuXi STA), announces their partner Innocare has received approval by the National Medical Products Administration of China (NMPA) for Orelabrutinib. Under the Marketing Authorization Holder (MAH) policy, WuXi STA provided an integrated and end-to-end support including drug substance, amorphous solid dispersion, tablet and packaging for this product. Just a couple months ago, with four WuXi STA’s sites inspected at the same time, WuXi STA successfully passed the pre-approval inspection (PAI) for Orelabrutinib from NMPA. From September 15 to October 3 in 2020, this comprehensive 18-day PAI involved four WuXi STA’s sites in China spanning drug substance manufacturing (Shanghai Jinshan), amorphous solid dispersions manufacturing using spray dried dispersion (SDD) (Changzhou), tablet manufacturing (Wuxi city), and drug substance process R&D, drug product R&D and clinical materials manufacturing (Shanghai Waigaoqiao). All of them
06-01-2021  |  070x  |  Industry news
ARCHIVE
JAN
2021
DEC
2020
NOV
2020
OCT
2020
SEPT
2020
AUG
2020
JULY
2020
JUNE
2020
MAY
2020
APR
2020
MAR
2020
FEB
2020
MAXUS MEDIA
LABinsights.net LABinsights.de LABinsights.nl
SIGN UP FOR OUR NEWSLETTER
Newsletter archive
Service and contact
ContactDisclaimerPrivacyAdvertising